Fully automated analysis of activities catalysed by the major human liver cytochrome P450 (CYP) enzymes: assessment of human CYP inhibition potential
- 1 January 1999
- journal article
- research article
- Published by Taylor & Francis in Xenobiotica
- Vol. 29 (1) , 53-75
- https://doi.org/10.1080/004982599238812
Abstract
1. Fully automated inhibition screens for the major human hepatic cytochrome P450s have been developed and validated. Probe assays were the fluorometric-based ethoxyresorufin O -deethylation for CYP1A2 and radiometric analysis of erythromycin N demethylation for CYP3A4, dextromethorphan O -demethylation for CYP2D6, naproxen O -demethylation for CYP2C9 and diazepam N -demethylation for CYP2C19. For the radiometric assays 99.7% of C-labelled substrate was routinely extracted from incubations by solid-phase extraction. 2. Furafylline, sulphaphenazole, omeprazole, quinidine and ketoconazole were identified as specific markers for the respective CYP1A2 (IC=6muM), CYP2C9 (0.7muM), CYP2C19 (6muM), CYP2D6 (0.02muM) and CYP3A4 (0.2muM) inhibition screens. 3. For the radiometric methods, a two-point IC estimate was validated by correlating the IC obtained with a full (seven-point) assay (r=0.98, p 0.001). The two-point IC estimate is useful for initial screening, while the full IC method provides more definitive quantitation, where required. 4. IC determined for a series of test compounds in human liver microsomes and cytochrome P450 cDNA-expressed enzymes were similar (r=0.89, p 0.001). In particular, the CYP1A2, CYP2D6 and CYP3A4 screens demonstrated the flexibility to accept either enzyme source. As a result of incomplete substrate selectivity, expressed enzymes were utilized for analysis of CYP2C9 and CYP2C19 inhibition. Good agreement was demonstrated between IC determined in these assays to IC published by other laboratories using a wide range of analytical techniques, which provided confidence in the universality of these inhibition screens. 5. These automated screens for initial assessment of P450 inhibition potential allow rapid determination of IC. The radiometric assays are flexible, sensitive, robust and free from analytical interference, and they should permit the identification and eradication of inhibitory structural motifs within a series of potential drug candidates.Keywords
This publication has 42 references indexed in Scilit:
- Metabolic interactions of selected antimalarial and non-antimalarial drugs with the major pathway (3-hydroxylation) of quinine in human liver microsomesPublished by Wiley ,1997
- Use of In Vitro and In Vivo Data to Estimate the Likelihood of Metabolic Pharmacokinetic InteractionsClinical Pharmacokinetics, 1997
- Selectivity of omeprazole inhibition towards rat liver cytochromes P450Xenobiotica, 1997
- Diazepam–omeprazole inhibition interaction: an in vitro investigation using human liver microsomesBritish Journal of Clinical Pharmacology, 1996
- Interaction of Sulfaphenazole Derivatives with Human Liver Cytochromes P450 2C: Molecular Origin of the Specific Inhibitory Effects of Sulfaphenazole on CYP 2C9 and Consequences for the Substrate Binding Site Topology of CYP 2C9Biochemistry, 1996
- The Substrate Binding Site of Human Liver Cytochrome P450 2C9: An Approach Using Designed Tienilic Acid Derivatives and Molecular ModelingBiochemistry, 1995
- Determination of P4501A2 activity in human liver microsomes using [3-14C-methyl]caffeineXenobiotica, 1995
- Drug Interactions and the Cytochrome P450 SystemClinical Pharmacokinetics, 1995
- Direct characterization of the selectivity of furafylline as an inhibitor of human cytochromes P450 1A1 and 1A2Pharmacogenetics, 1994
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973